At the University of Colorado Cancer Center, Jorge Monge, MD, highlighted groundbreaking advancements in multiple myeloma treatments that have revolutionized patient care. He emphasized the importance of evolving therapies in enhancing quality of life while addressing financial toxicity concerns.